Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Portable reading device with mode processing
Anti-infective agents and uses thereof
Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
Method of requesting CQI reports
Substituted thiophene pentamers
Using location based services for determining a calling window
Method and apparatus for communication channel error rate estimation
  Randomly Featured Patents
Method and device for conditioning the coating of a paper machine roll
Stuffed fish toy
Translated memory protection apparatus for an advanced microprocessor
Locking joint machine
Photosensitive resin composition
Throttle control system having manual and automatic modes of operation
Copper salts of thiodipropionic acid derivatives as antioxidant additives and lubricant compositions thereof
Process to prepare a hydrogen rich gas mixture
Plants with modified stamen cells
Gem setting